FDA.reportPublic FDA data

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN Pharmacologic Class Indexing

Class set ID
6b5d013f-2c26-4166-9384-b5f0cac9691d
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2018MSP Vaccine Company | Sanofi Vaccines Canada Ltd. | Sanofi Winthrop Industrie | Merck Sharp & Dohme Corp.2026042814
These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Suspension for Intramuscular Injection Initial U.S. Approval: 2018A-S Medication Solutions202505131
PedvaxHIB ® Liquid [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)]Merck Sharp & Dohme LLC2024102219
H. INFLUENZAE TYPEB CONJ HIB MRKPRP EUMerck Sharp & Dohme Corp.201508052